News
Videos
Conferences
Events
Resources
Subscribe

|Videos|December 29, 2022

Healthcare Team Members Involved in Treating Myeloproliferative Neoplasms

Author(s)Ruben Mesa, M.D., Rami S. Komrokji, M.D.

Comprehensive insight on the various healthcare team members a hematologist-oncologist may work with to optimize care of myeloproliferative neoplasms.

Episodes in this series

Experts on MPNs

EP. 1 A Background on Myeloproliferative Neoplasms

Expert on MPNs

EP. 2 How Are Myeloproliferative Neoplasms Diagnosed?

Expert on MPNs

EP. 3 Overview on the Management of Essential Thrombocythemia and Polycythemia Vera

Experts on MPN

EP. 4 Overview of Treatment Options for Myelofibrosis

Expert on MPNs

EP. 5 Healthcare Team Members Involved in Treating Myeloproliferative Neoplasms

Expert on MPNs

EP. 6 Adverse Events Tied to Treatment for Myeloproliferative Neoplasms

Experts on MPNs

EP. 7 Novel Treatment Strategies in Essential Thrombocythemia and Polycythemia Vera

Expert on MPNs

EP. 8 Myelofibrosis: Novel Treatment Strategies and Combination Therapies

Expert on MPNs

EP. 9 MF Progression to Acute Myeloid Leukemia and Subsequent Treatment

Newsletter

Stay up to date on cancer updates, research and education

Related Content

The FDA has granted orphan drug designation to zavabresib, an investigational therapy for the treatment of myelofibrosis, a rare blood cancer: © stock.adobe.com.

FDA Orphan Drug Designation Granted to Zavabresib for Myelofibrosis

January 22nd 2026

Image of "FDA"

FDA Accepts Besremi Application for Essential Thrombocythemia

BySpencer Feldman

January 13th 2026

Mayra Andujar-Delgado shares her 10-year myelofibrosis journey and how 2025 Blood Cancer Hero Dr. Faseeh Khaja empowered her and her husband.

A Decade of Patient Proactivity and Physician Partnership

ByMayra Andujar-Delgado

January 11th 2026

Image of blood.

FDA Grants Orphan Drug Designation to CK0804 for Myelofibrosis

BySpencer Feldman

January 9th 2026

FDA sign image

FDA Application Submitted for Rusfertide Treatment in Polycythemia Vera

January 6th 2026

Trending on CURE

Key Patient Takeaways From the 2026 ASCO GI Cancers Symposium

10 Things I Learned After 10 Years With Ovarian Cancer

FDA Approves Guardant360 CDx Diagnostic For Some With Colorectal Cancer

New Test May Predict Chemo Benefit in Breast Cancer

Adjuvant Temozolomide Improves Survival in 1p/19q Non-Co-Deleted Glioma